| 1 |
end-stage renal disease
(13713 times)
|
Nephrology
(5186 times)
|
CKD (1678 times)
HD (1508 times)
PD (746 times)
|
1974 Patient financing in the first year of the end-stage renal disease (esrd) program.
|
| 2 |
end-stage renal failure
(69 times)
|
Nephrology
(37 times)
|
HD (8 times)
CAPD (5 times)
CRF (4 times)
|
1985 Sequential sodium therapy allows correction of sodium-volume balance and reduces morbidity.
|
| 3 |
end-stage renal disease patients
(32 times)
|
Nephrology
(11 times)
|
HD (9 times)
HCV (4 times)
PD (3 times)
|
1991 The urine urokinase concentration in end stage renal disease with acquired renal cyst.
|
| 4 |
End Stage Renal Diseases
(8 times)
|
Nephrology
(3 times)
|
HD (2 times)
Cn (1 time)
Cr (1 time)
|
1989 Medicare's ESRD Program, Part 1: Dialysis.
|
| 5 |
patients withend-stage renal disease
(5 times)
|
Kidney Diseases
(1 time)
|
HD (2 times)
CVD (1 time)
ELISA (1 time)
|
2005 Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients.
|
| 6 |
end-stage chronic kidney disease
(4 times)
|
Social Medicine
(1 time)
|
RRT (2 times)
ChLGI (1 time)
ChSI (1 time)
|
2003 End-stage renal disease in North Africa.
|
| 7 |
end-stage renal disease on dialysis
(4 times)
|
Cardiology
(2 times)
|
CKD (2 times)
DM (1 time)
HDLs (1 time)
|
2014 Dysfunctional high-density lipoproteins in children with chronic kidney disease.
|
| 8 |
end stage renal dysfunction
(3 times)
|
Vascular Diseases
(1 time)
|
ARAS (1 time)
AUC (1 time)
CI (1 time)
|
2005 Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis.
|
| 9 |
end-stage kidney failure
(2 times)
|
Public Health
(1 time)
|
AASK (1 time)
CKD (1 time)
NIDDK (1 time)
|
1998 African American Study of Kidney Disease and hypertension (AASK)--clinical trial update.
|
| 10 |
end-stage renal dialysis
(2 times)
|
Jurisprudence
(1 time)
|
---
|
1980 Health Care Financing Administration--conditions for coverage of suppliers of ESRD services; revocation of requirements for emergency generator and ground fault interrupters. Final rule.
|
| 11 |
end-stage stage renal disease
(2 times)
|
Cardiovascular Diseases
(1 time)
|
CKD (1 time)
CS (1 time)
CVA (1 time)
|
2022 Cardiovascular outcomes of transradial versus transfemoral percutaneous coronary intervention in End-Stage renal Disease: A Regression-Based comparison.
|
| 12 |
ESRD group
(2 times)
|
General Surgery
(1 time)
|
AKI (1 time)
CECT (1 time)
CKD (1 time)
|
2001 Liver resection for hepatocellular carcinoma in patients with end-stage renal failure.
|
| 13 |
diagnoses-end-stage renal disease
(1 time)
|
Neurology
(1 time)
|
COPD (1 time)
HF (1 time)
|
2017 Comparing the Palliative Care Needs of Those With Cancer to Those With Common Non-Cancer Serious Illness.
|
| 14 |
eg, diabetes, glomerulonephritis
(1 time)
|
Nephrology
(1 time)
|
ADL (1 time)
ANCOVA (1 time)
ANOVA (1 time)
|
1989 Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates.
|
| 15 |
eg, diabetes, hypertension
(1 time)
|
Nephrology
(1 time)
|
CI (1 time)
|
2004 Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
|
| 16 |
elevated cardiovascular risk, beingend-stage renal disease
(1 time)
|
Endocrinology
(1 time)
|
CN (1 time)
CNV (1 time)
|
2020 AMY1 diploid copy number among end-stage renal disease patients.
|
| 17 |
end stage renal disease failure
(1 time)
|
Kidney Diseases
(1 time)
|
AVF (1 time)
|
2015 Oral prostacycline analog and clopidogrel combination provides early maturation and long-term survival after arteriovenous fistula creation: A randomized controlled study.
|
| 18 |
End Stage Renal Disease in Mexico
(1 time)
|
Public Health
(1 time)
|
---
|
2012 [An indirect estimation of current and future inequalities in the frequency of end stage renal disease in Mexico].
|
| 19 |
end stage renal disease in people
(1 time)
|
Endocrinology
(1 time)
|
BMs (1 time)
DEGs (1 time)
DN (1 time)
|
2023 Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
|
| 20 |
end stage renal disease on maintenance hemodialysis
(1 time)
|
Behavioral Sciences
(1 time)
|
NC (1 time)
NPT (1 time)
|
1983 Consecutive-night reliability of portable nocturnal penile tumescence monitor.
|
| 21 |
end stage renal failure patients
(1 time)
|
Clinical Medicine
(1 time)
|
CAPD (1 time)
CI (1 time)
CVD (1 time)
|
2016 Predictor of cardiovascular risks in end stage renal failure patients on maintenance dialysis.
|
| 22 |
end-stage chronic renal insufficiency
(1 time)
|
Vascular Diseases
(1 time)
|
LVH (1 time)
rHuEPO (1 time)
|
2000 Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO).
|
| 23 |
end-stage liver disease
(1 time)
|
|
HCC (1 time)
NAFLD (1 time)
NASH (1 time)
|
2021 Treatment of Fatty Liver Disease: The Present and the Future.
|
| 24 |
end-stage nephropathy
(1 time)
|
Medicine
(1 time)
|
CAR (1 time)
CETSA (1 time)
DN (1 time)
|
2020 Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
|
| 25 |
end-stage phase of renal disease
(1 time)
|
Nephrology
(1 time)
|
ARIC (1 time)
CKD (1 time)
CV (1 time)
|
2008 The burden of cardiovascular disease in patients with chronic kidney disease and in end-stage renal disease.
|
| 26 |
end-stage renal
(1 time)
|
Rehabilitation
(1 time)
|
USRDS (1 time)
|
2001 Disability under Social Security for patients with ESRD: an evidence-based review.
|
| 27 |
end-stage renal disease and/or death
(1 time)
|
General Surgery
(1 time)
|
CYC (1 time)
WG (1 time)
|
2007 Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement.
|
| 28 |
end-stage renal disease during the course of the disease
(1 time)
|
|
CKD (1 time)
eGFR (1 time)
IF (1 time)
|
2020 Clinical significance of IgM deposition in pediatric minimal change disease.
|
| 29 |
end-stage renal disease patients on dialysis
(1 time)
|
Nephrology
(1 time)
|
pre-dialysis CKD (1 time)
PSQI (1 time)
|
2017 A comparison of quality of sleep between patients with chronic kidney disease not on hemodialysis and end-stage renal disease on hemodialysis in a developing country.
|
| 30 |
end-stage renal disease requiring haemodialysis
(1 time)
|
Hematology
(1 time)
|
AEs (1 time)
CrCl (1 time)
MM (1 time)
|
2016 A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis.
|
| 31 |
end-stage renal failure or disease
(1 time)
|
Drug Discovery
(1 time)
|
HBV (1 time)
HCV (1 time)
HD (1 time)
|
2019 Profile and predictors of hepatitis and HIV infection in patients on hemodialysis of Quetta, Pakistan.
|
| 32 |
endpoint was requiring dialysis or transplant
(1 time)
|
Rheumatology
(1 time)
|
LN (1 time)
SCr (1 time)
SLE (1 time)
|
2006 Renal outcomes in children with lupus and a family history of autoimmune disease.
|
| 33 |
ESRD but without liver disease
(1 time)
|
Kidney Transplantation
(1 time)
|
ALD (1 time)
BMI (1 time)
CAPD (1 time)
|
2013 The use of continuous ambulatory peritoneal dialysis for patients with end-stage renal disease and pre-existing advanced liver disease.
|
| 34 |
ESRD, age
(1 time)
|
Nephrology
(1 time)
|
ADPKD (1 time)
Ccr (1 time)
|
2005 Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
|
| 35 |
ESRD-cirrhosis
(1 time)
|
Nephrology
(1 time)
|
HD (1 time)
NIS (1 time)
PD (1 time)
|
2017 In-Hospital Mortality in Cirrhotic Patients with End-Stage Renal Disease Treated with Hemodialysis Versus Peritoneal Dialysis: A Nationwide Study.
|
| 36 |
ESRD-GC group
(1 time)
|
Neoplasms
(1 time)
|
GC (1 time)
LN (1 time)
RG (1 time)
|
2015 Gastric cancer patients with end-stage renal disease who underwent radical gastrectomy.
|
| 37 |
established as the treatment of choice forend-stage renal disease
(1 time)
|
Transplantation
(1 time)
|
CI (1 time)
mTORi (1 time)
OR (1 time)
|
2016 Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.
|
| 38 |
exist: for those that have completely lost their kidney function
(1 time)
|
Organogenesis
(1 time)
|
CKD (1 time)
MSC (1 time)
|
2011 Selecting the optimal cell for kidney regeneration: fetal, adult or reprogrammed stem cells.
|
| 39 |
expression was tested in six anemic chronic hemodialysis
(1 time)
|
Nephrology
(1 time)
|
rEPO (1 time)
SLE (1 time)
|
1994 Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35).
|
| 40 |
HIVAN-end stage renal disease
(1 time)
|
Pharmacology
(1 time)
|
cART (1 time)
HIV (1 time)
HIVAN (1 time)
|
2017 Pharmacotherapy and treatment options for HIV-associated nephropathy.
|
| 41 |
more severe renal disease and worse renal outcomes
(1 time)
|
Nephrology
(1 time)
|
AAV (1 time)
IF (1 time)
|
2020 Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study.
|
A Search Service for Abbreviation / Long Form